Inhaled Delivery of Biologics: Why it’s a Good Solution

3/23/2022 12:25 - 12:55

Biologics present numerous challenges in their successful manufacture, formulation, and delivery to the patient. Respiratory delivery of biologics presents opportunities for both targeted delivery of these drug substances as well as alternative systemic delivery routes to the traditional needle-based administration options currently used. This presentation will discuss the available technologies and approaches being used to build effective products, as well as a discussion of the regulatory considerations when taking this complex combination of new drug modalities and delivery routes through to market.

Mark Parry, Technical Director, Intertek Melbourn